These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 24450487

  • 1. Extended cycle combined oral contraceptives and prophylactic frovatriptan during the hormone-free interval in women with menstrual-related migraines.
    Coffee AL, Sulak PJ, Hill AJ, Hansen DJ, Kuehl TJ, Clark JW.
    J Womens Health (Larchmt); 2014 Apr; 23(4):310-7. PubMed ID: 24450487
    [Abstract] [Full Text] [Related]

  • 2. A randomized trial of frovatriptan for the intermittent prevention of menstrual migraine.
    Silberstein SD, Elkind AH, Schreiber C, Keywood C.
    Neurology; 2004 Jul 27; 63(2):261-9. PubMed ID: 15277618
    [Abstract] [Full Text] [Related]

  • 3. Safety and tolerability of short-term preventive frovatriptan: a combined analysis.
    MacGregor EA, Brandes JL, Silberstein S, Jeka S, Czapinski P, Shaw B, Pawsey S.
    Headache; 2009 Oct 27; 49(9):1298-314. PubMed ID: 19788471
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics of two 6-day frovatriptan dosing regimens used for the short-term prevention of menstrual migraine: A phase I, randomized, double-blind, placebo-controlled, two-period crossover, single-centre study in healthy female volunteers.
    Wade A, Pawsey S, Whale H, Boyce M, Warrington S.
    Clin Drug Investig; 2009 Oct 27; 29(5):325-37. PubMed ID: 19366274
    [Abstract] [Full Text] [Related]

  • 5. Scheduled short-term prevention with frovatriptan for migraine occurring exclusively in association with menstruation.
    Silberstein SD, Berner T, Tobin J, Xiang Q, Campbell JC.
    Headache; 2009 Oct 27; 49(9):1283-97. PubMed ID: 19751371
    [Abstract] [Full Text] [Related]

  • 6. Short-term frovatriptan for the prevention of difficult-to-treat menstrual migraine attacks.
    Brandes JL, Poole Ac, Kallela M, Schreiber CP, MacGregor EA, Silberstein SD, Tobin J, Shaw R.
    Cephalalgia; 2009 Nov 27; 29(11):1133-48. PubMed ID: 19811503
    [Abstract] [Full Text] [Related]

  • 7. Frovatriptan vs. other triptans for the acute treatment of oral contraceptive-induced menstrual migraine: pooled analysis of three double-blind, randomized, crossover, multicenter studies.
    Allais G, Tullo V, Omboni S, Pezzola D, Zava D, Benedetto C, Bussone G.
    Neurol Sci; 2013 May 27; 34 Suppl 1(Suppl 1):S83-6. PubMed ID: 23695052
    [Abstract] [Full Text] [Related]

  • 8. Safety and tolerability of frovatriptan in the acute treatment of migraine and prevention of menstrual migraine: Results of a new analysis of data from five previously published studies.
    MacGregor EA, Pawsey SP, Campbell JC, Hu X.
    Gend Med; 2010 Apr 27; 7(2):88-108. PubMed ID: 20435272
    [Abstract] [Full Text] [Related]

  • 9. Headaches and oral contraceptives: impact of eliminating the standard 7-day placebo interval.
    Sulak P, Willis S, Kuehl T, Coffee A, Clark J.
    Headache; 2007 Jan 27; 47(1):27-37. PubMed ID: 17355491
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and tolerability of naratriptan for short-term prevention of menstrually related migraine: data from two randomized, double-blind, placebo-controlled studies.
    Mannix LK, Savani N, Landy S, Valade D, Shackelford S, Ames MH, Jones MW.
    Headache; 2007 Jan 27; 47(7):1037-49. PubMed ID: 17635595
    [Abstract] [Full Text] [Related]

  • 11. Long-term assessment of symptomatology and satisfaction of an extended oral contraceptive regimen.
    Coffee AL, Sulak PJ, Kuehl TJ.
    Contraception; 2007 Jun 27; 75(6):444-9. PubMed ID: 17519150
    [Abstract] [Full Text] [Related]

  • 12. Effect of a contraceptive pill containing estradiol valerate and dienogest (E2V/DNG) in women with menstrually-related migraine (MRM).
    Nappi RE, Terreno E, Sances G, Martini E, Tonani S, Santamaria V, Tassorelli C, Spinillo A.
    Contraception; 2013 Sep 27; 88(3):369-75. PubMed ID: 23453784
    [Abstract] [Full Text] [Related]

  • 13. Oral contraceptive-induced menstrual migraine. Clinical aspects and response to frovatriptan.
    Allais G, Bussone G, Airola G, Borgogno P, Gabellari IC, De Lorenzo C, Pavia E, Benedetto C.
    Neurol Sci; 2008 May 27; 29 Suppl 1():S186-90. PubMed ID: 18545931
    [Abstract] [Full Text] [Related]

  • 14. A prospective follow-up of two 21/7 cycles followed by two extended regimen 84/7 cycles with contraceptive pills containing ethinyl estradiol and drospirenone.
    Seidman DS, Yeshaya A, Ber A, Amodai I, Feinstein I, Finkel I, Gordon N, Porat N, Samuel D, Shiran-Makler E, Wolman I.
    Isr Med Assoc J; 2010 Jul 27; 12(7):400-5. PubMed ID: 20862819
    [Abstract] [Full Text] [Related]

  • 15. Two center, randomized pilot study of migraine prophylaxis comparing paradigms using pre-emptive frovatriptan or daily topiramate: research and clinical implications.
    Cady RK, Voirin J, Farmer K, Browning R, Beach ME, Tarrasch J.
    Headache; 2012 May 27; 52(5):749-64. PubMed ID: 22188311
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of pituitary-ovarian axis suppression with three oral contraceptive regimens.
    Vandever MA, Kuehl TJ, Sulak PJ, Witt I, Coffee A, Wincek TJ, Reape KZ.
    Contraception; 2008 Mar 27; 77(3):162-70. PubMed ID: 18279685
    [Abstract] [Full Text] [Related]

  • 17. Temporal relations in hormone-withdrawal migraines and impact on prevention- a diary-based pilot study in combined hormonal contraceptive users.
    Merki-Feld GS, Epple G, Caveng N, Imthurn B, Seifert B, Sandor P, Gantenbein AR.
    J Headache Pain; 2017 Aug 25; 18(1):91. PubMed ID: 28842849
    [Abstract] [Full Text] [Related]

  • 18. Frovatriptan as preemptive treatment for fasting-induced migraine.
    Latsko M, Silberstein S, Rosen N.
    Headache; 2011 Mar 25; 51(3):369-374. PubMed ID: 21269298
    [Abstract] [Full Text] [Related]

  • 19. Effects of an extended flexible regimen of an oral contraceptive pill containing 20 μg ethinylestradiol and 3 mg drospirenone on menstrual-related symptoms: a randomised controlled trial.
    Machado RB, Pompei LM, Badalotti M, Ferriani R, Cruz AM, Nahas E, Maia H.
    Eur J Contracept Reprod Health Care; 2017 Feb 25; 22(1):11-16. PubMed ID: 27684740
    [Abstract] [Full Text] [Related]

  • 20. Frovatriptan versus almotriptan for acute treatment of menstrual migraine: analysis of a double-blind, randomized, cross-over, multicenter, Italian, comparative study.
    Bartolini M, Giamberardino MA, Lisotto C, Martelletti P, Moscato D, Panascia B, Savi L, Pini LA, Sances G, Santoro P, Zanchin G, Omboni S, Ferrari MD, Fierro B, Brighina F.
    J Headache Pain; 2012 Jul 25; 13(5):401-6. PubMed ID: 22592864
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.